Novo Nordisk's ZEUS study found ziltivekimab lowered IL-6 levels but did not reduce heart attacks, strokes or deaths. The results were presented at the AHA conference.
7 November 2026: Novo Nordisk's ziltivekimab fails to cut heart events in ZEUS trial. Novo Nordisk's ZEUS study found ziltivekimab lowered IL-6 levels but did not reduce heart attacks, strokes or deaths. The results were presented at the AHA conference.
What is Clinical Trials news usually about?+
Most often mentioned alongside Clinical Trials: Biotech, Pharma. The main topic is macro.
How can I get Clinical Trials news sooner?+
Stories appear on the website as soon as they are checked. In your account you can set up alerts by keyword, and the API delivers the same feed to your bots and dashboards.